Business Wire

Milrem Robotics’ THeMIS UGV Has Become the Industry Standard

Del

The THeMIS unmanned ground vehicle (UGV) developed by Milrem Robotics has become the unmanned ground systems industries standard tracked UGV. During this year’s Eurosatory a record of four THeMIS UGVs will be displayed with three different applications.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180611006357/en/

(Photo: Business Wire)

(Photo: Business Wire)

In just a few years after the development of the THeMIS began, it has become the most sought after tracked unmanned ground vehicle on the market. It has caught interest from several weapon and other warfare systems manufacturers like Nexter, FN Herstal, ST Kinetics, Raytheon and Threod Systems with whom integration projects are underway or have already been completed.

Unlike other UGVs that are commonly able to perform mostly one task, the THeMIS is designed so it can be equipped with a vast variety of payloads to perform a number of different tasks.

These include functioning as a remote weapon station outfitted with large or small calibre weapons, detecting IED’s, operating as a drone platform or a remote surveillance station.

At Eurosatory three such integrated products will be exhibited: the THeMIS with Nexter’s ARX20 RWS, THeMIS with Threod Systems UAV and the THeMIS with deFNder RWS from FN Herstal. The latter will be exhibited at FN Herstal’s booth as well as at the dynamic demonstrations area.

“The Threod Systems Tethered UAV and THeMIS integration is a notable capability multiplier. The system provides a fully autonomous ISR tool for information collection, reporting, situational awareness and situational understanding. Moreover, the system works as a radio relay to extend network coverage in the area,” stated Villiko Nurmoja, CEO of Threod Systems.

“OPTIO X-20 which is the combination of the THEMIS platform and our ARX20 - 20mm RCWS - makes a fantastically capable system by merging outstanding fire power and mobility capabilities,” said Frédéric Bouty, Director of Strategy Department of NEXTER.

"The combined solution of deFNder® Medium and THeMIS, merging the technologies and expertise of our two companies, illustrates the potential of the concept", said Vincent Verleye, COO of FN Herstal. "The added value of such a weaponized robotic system is self-explanatory, and FN Herstal, as a leading defence weapon systems integrator, is proud to demonstrate the deFNder® Medium RWS during Eurosatory dynamic demonstrations alongside Milrem Robotics," he added.

”Milrem Robotics’ THeMIS has become very popular platform as we have been down selected in number of different assessment, development and testing programs in US, UK, Norway, Estonia and other countries,” stated Kuldar Väärsi, CEO of Milrem Robotics. “The reason for that is the modularity, simplicity and robustness of our system. The next big step in our strategy will be related to autonomy and manned-unmanned teaming solutions.”

Contact information

Milrem Robotics
Gert Hankewitz, +372 56644416
Export Director
gert.hankewitz@milrem.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Lenovo Accelerates Turnaround with Back-to-Back, Double-Digit Quarterly Revenue Growth15.8.2018 23:40Pressemelding

Lenovo Group (HKSE: 0992) (PINK SHEETS: LNVGY) today announced results for its first fiscal quarter ended June 30, 2018. For the second straight quarter, Lenovo achieved strong double-digit growth in revenue year-on-year. Group revenue reached US$11.91 billion, up 19% year-on-year. The company also reported strong pre-tax income during the quarter of US$113 million, an improvement of US$182 million year-on-year, as profitability improved across all businesses. In the first fiscal quarter, Lenovo’s profit attributable to equity holders grew to US$77 million, up US$149 million year-over-year. Basic earnings per share in the first fiscal quarter was 0.65 US cents or 5.10 HK cents. “As we persistently execute our 3-wave strategy, all our businesses made solid improvements in both revenue and profitability. Lenovo has passed the turning point and entered a phase of ‘acceleration’ - accelerating the execution of our transformation strategy and accelerating the rising momentum in business per

CORRECTING and REPLACING Ebola Successfully Neutralized by Latest Generation Polyclonal Immunotherapy15.8.2018 22:37Pressemelding

Please replace the release with the following corrected version due to multiple revisions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180815005602/en/ New Ebola immunotherapy developed by SAB Biotherapeutics uses natural human polyclonal antibodies to combat disease. (Photo: SAB Biotherapeutics) The corrected release reads: EBOLA SUCCESSFULLY NEUTRALIZED BY LATEST GENERATION POLYCLONAL IMMUNOTHERAPY Promising new platform can rapidly respond to emerging infectious diseases Sioux Falls, SD, August 15, 2018 – SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided “100% protection against a lethal dose of the Ebola virus” in a recent animal study published in The Journal of Infectious Diseases . The study was conducted at the Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of He

Ebola Successfully Neutralized by Latest Generation Polyclonal Immunotherapy15.8.2018 17:43Pressemelding

SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided “100% protection against a lethal dose of the Ebola virus” in a recent animal study published in The Journal of Infectious Diseases . The study was conducted by the National Interagency Confederation for Biological Research and other collaborators including United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and the Naval Medical Research Center (NMRC). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180815005602/en/ New Ebola immunotherapy developed by SAB Biotherapeutics uses natural human polyclonal antibodies to combat disease. (Photo: SAB Biotherapeutics) According to the World Health Organization, Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe, often fatal illness in humans with an average fatality rate around 50%.

Rimini Street Receives Asia-Pacific Stevie Award for Customer Service Innovation15.8.2018 17:05Pressemelding

Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, and the leading third-party support provider for Oracle and SAP software products, today announced it has been honored with a Stevie® Award in the Innovation in Customer Service Management, Planning & Practice category for its ultra-responsive, premium level service in the Asia-Pacific region. This honor marks the Company’s 12th Stevie Award win this year, and the second consecutive year the Company has been recognized by the Asia-Pacific Stevie Awards. Rimini Street recently earned Stevie Awards in several categories, including Company of the Year from the 2018 American Business Awards® and Customer Service Department of the Year from the 2018 Stevie Awards for Sales & Customer Service. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180815005580/en/ Rimini Street Receives Asia-Pacific Stevie Award for Customer Service Innovat

2018 Healthcare+ Expo Taiwan: Where Tech Meets Medicine15.8.2018 13:03Pressemelding

From November 29th to December 2nd 2018, global-leading biomedical and technology institutes will gather in Taipei for the top healthcare and technology event in Asia - The Healthcare+ Expo - Taiwan. In line with the theme “Med X Tech”, a lineup of global leaders in technology will share the latest technology advancements and how technology create better solutions for future medical applications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180815005001/en/ This year, the expo gathers 400 + world-class medical institutes and multi-national IT/ICT/electronic giants. The IT giants will showcase medical innovations of AI, IoT and robotic technologies. The medical institutes will demonstrate advanced medical technologies, smart hospital designs, products, and services while bio-pharmaceutical, medical device, and genetic enterprises will provide the most current updates in precision medicine. In all, more than 1,400 booths wil

QConnect - The Most Intelligent, Global, Ultra-Compact, Rugged Communication Device15.8.2018 13:00Pressemelding

Quake Global, Inc. (QUAKE), a leading provider of solutions to the global IoT market, announced the launch of their advanced telematics device, QConnect™. The Ultra-compact QConnect integrates with fixed and mobile assets for real-time tracking, monitoring and control anywhere, anytime. The device provides a variety of advanced, wireless communication options, including LTE/2G/3G, dual-band Wi-Fi, Bluetooth/BLE, V2X, and satellite. The device is designed to meet the demands of a wide variety of requirements from simple low-cost tracking applications to high-performance, multi-channel, video streaming applications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180815005104/en/ Quake Global’s new QConnect, the most intelligent, global, ultra-compact and rugged communication device available (Photo: Business Wire) QConnect is flexible with unique apps and software options on an open source Linux platform. Control your vision w